Does PALBOCICLIB Cause Type 2 diabetes mellitus? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Type 2 diabetes mellitus have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
48
Reports of Type 2 diabetes mellitus with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
5
Deaths
12
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From PALBOCICLIB?
Of the 48 reports, 5 (10.4%) resulted in death, 12 (25.0%) required hospitalization.
Is Type 2 diabetes mellitus Listed in the Official Label?
Yes, Type 2 diabetes mellitus is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which PALBOCICLIB Alternatives Have Lower Type 2 diabetes mellitus Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID